Hepatic Biomarker Profile Across Parkinson’s Disease Severity Stages in a Peruvian Cohort
Objective: To determine changes in serum hepatic biomarker concentrations according to Parkinson's disease (PD) severity in Peruvian adults. Background: PD is a progressive neurodegenerative disorder.…The Effect of Depression on the Cognitive Phenotype in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia.
Objective: To investigate the impact of depression on cognitive functioning in a group of older adults without dementia. Background: Parkinson’s disease (PD) is a neurodegenerative…Bridging the Gap: Physical Activity and Rehabilitation Patterns in Patients with Parkinsonism
Objective: Characterize physical activity participation and rehabilitation referral patterns among patients with parkinsonism. Background: Parkinson's disease (PD) and other parkinsonisms are frequently associated with significant…Electrocardiographic Indicators of Autonomic Dysfunction in Parkinson’s Disease: A Scoping Review and Meta-analysis
Objective: To systematically map and quantitatively synthesize evidence on ECG-derived markers associated with autonomic dysfunction in PD and evaluate their ability to differentiate patients from…Skin Tau Quantification as a Potential Degeneration Biomarker in Parkinson’s Disease
Objective: This cross-sectional observational study aims to quantify total skin Tau levels in Parkinson’s disease (PD) patients and explore their association with clinical symptoms. Background:…Unnecessary Ablative Surgery in an Untreated Parkinson’s Disease Patient: Marked Clinical Improvement After Initiation of Dopaminergic Therapy
Objective: To report a case of Parkinson’s disease (PD) in which two ablative procedures were performed without prior dopaminergic therapy, followed by significant clinical improvement…Risk factors for dysautonomic fluctuations in Mexican PwP
Objective: To identify risk factors for non-motor dysautonomic fluctuations in people living with Parkinson’s disease (PwP). Background: Advanced Parkinson’s disease (PD) is characterized by motor…Levodopa Initiation in Phase 3 Trials of Tavapadon, a Selective D1/D5 Agonist for Early Parkinson’s Disease
Objective: To evaluate motor improvements in adults with early Parkinson’s disease (PD) who initiated levodopa (LD) during phase 3 trials of tavapadon. Background: Tavapadon, an…Engage-Qatar PD (EQP): Pilot RCT of a Remote Coaching Intervention Using Online Platform to Promote Engagement in Physical Activity in People with Parkinson’s Disease in Qatar.
Objective: Evaluate the effect of the EQP program, on Physical Activity (PA) participation and functional walking capacity among people with Parkinson’s disease (PwP) compared with…Dynamics of Motor Fluctuations and Medication Challenges in Parkinson’s Disease
Objective: To investigate the dynamics of tremor, bradykinesia, and finger dexterity during the OFF-to-ON transition using objective measures. Additionally, assesses medication administration challenges through a…
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 553
- Next Page »